Role of fibroblast growth factor 23 in the development of cardiovascular diseases in patients with end-stage renal failure on programmed hemodialysis

Aim. To determine the nature of changes in fibroblast growth factor 23 (FGF-23) and other bone mineral metabolism parameters detectable in the blood of patients with end-stage chronic renal failure (CRF) and to analyze their links to the development of cardiovascular events in uremic intoxication. S...

Full description

Bibliographic Details
Main Authors: F U Dzgoeva, M Yu Sopoev, T L Bestaeva, O V Khamitsaeva, F A Ktsoeva, R O Sageeva
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2016-12-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/32079/pdf